Evidence map›Paper›PMID 42729668›Full record

ArticleCancer drug resistance (Alhambra, Calif.)2026

TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cells.

Eleicy Nathaly Mendoza, Serena Castelli, Angela De Cristofaro, Enrico Desideri, Grazia Graziani, Pedro Miguel Lacal, Maria Rosa Ciriolo, Fabio Ciccarone

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer drug resistance (Alhambra, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eleicy Nathaly MendozaDepartment of Biology, University of Rome Tor Vergata, Rome 00157, Italy.
Serena CastelliDepartment for the Promotion of Human Science and Quality of Life, San Raffaele Open University, Rome 00166, Italy.
Angela De CristofaroDepartment of Biology, University of Rome Tor Vergata, Rome 00157, Italy.
Enrico DesideriDepartment of Life Sciences, Health and Health Professions, Link Campus University, Rome 00165, Italy.
Grazia GrazianiDepartment of Systems Medicine, University of Rome Tor Vergata, Rome 00133, Italy.
Pedro Miguel LacalLaboratory of Molecular Oncology, IDI-IRCCS, Rome 00167, Italy.
Maria Rosa CirioloDepartment of Biology, University of Rome Tor Vergata, Rome 00157, Italy.
Fabio CiccaroneDepartment of Biology, University of Rome Tor Vergata, Rome 00157, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

5hmCBRAF inhibitorsdrug resistanceoxidative stress

Identifiers

PMID42729668
PMCPMC13563456

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.